Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Rapid Detection Of Pathogens Is High Priority In Need Of Technology

This article was originally published in The Tan Sheet

Executive Summary

FDA Associate Commissioner for Foods David Acheson says the search continues for an "out-of-the-box" technology to rapidly detect salmonella in foods starting in 2009

You may also be interested in...



FDA Strategic Documents Outline Regulatory Science Priorities

Improving regulatory tools and scientific know-how are among FDA's top priorities over the next five years, according to a draft strategic report

FDA Strategic Documents Outline Regulatory Science Priorities

Improving regulatory tools and scientific know-how are among FDA's top priorities over the next five years, according to a draft strategic report

FDA Strategic Documents Outline Regulatory Science Priorities

Improving regulatory tools and scientific know-how are among FDA's top priorities over the next five years, according to a draft strategic report

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS102951

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel